Home » Newsletters » BioWorld

BioWorld

May 6, 1993

View Archived Issues

HYGEIA PREPARES FOR PRIVATE PLACEMENT

IMMUNEX MERGER STATEMENT DECLARED EFFECTIVE

MAGAININ GETS PATENT FOR ANTIBIOTIC

SERAGEN REPORTS PHASE II RESULTS

PHARMAKON MOUSE SCREENS FOR DIABETES DRUGS

ISIS SAFETY DATA PRESENTED

GENSIA RESEARCH TARGETS INFLAMMATION

GENZYME ACQUIRES ITALIAN COMPANY

GENZYME REPORTS ON GAUCHER'S DRUG

COLORECTAL CANCER GENE DISCOVERED

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026